Key result
CTO PCI linked to ~54% lower risk of major events vs planned complex non-CTO PCI.
Why the study?
Data regarding long-term outcomes of CTO PCI are limited, with no direct comparisons available against planned complex non-CTO PCI.
Does chronic total occlusion (CTO) PCI reduce the combined endpoint of all-cause death, myocardial infarction, and target vessel revascularization compared to planned complex non-CTO PCI in patients undergoing planned complex PCI?
Cohort (n=1,001)
No
Does chronic total occlusion (CTO) PCI reduce the combined endpoint of all-cause death, myocardial infarction, and target vessel revascularization compared to planned complex non-CTO PCI in patients undergoing planned complex PCI?
In patients undergoing planned complex PCI, CTO revascularization was associated with a significantly lower long-term risk of death, MI, and target vessel revascularization compared to complex non-CTO PCI.
Answers are grounded in this paper and cite their sources.
Should not yet change complex PCI practice; leaves open whether randomized trials confirm CTO benefit.
Introduction: The number of chronic total occlusion (CTO) revascularization procedures has continuously increased, obtaining better results in recent years. However, there are few data regarding long-term outcomes and no comparisons to planned complex non-CTO percutaneous coronary intervention (PCI). Methods: We included all patients undergoing planned complex PCI. Our main objective was to compare a combined endpoint of all-cause death, myocardial infarction, and target vessel revascularization at the long-term follow-up of CTO PCI versus planned complex non-CTO PCI. We compared the groups using multivariable Cox regression and performed a propensity score matching analysis to control the baseline characteristics. We repeated the analysis for the separate components of the primary endpoint. Results: From January 2018 to June 2023, 1394 complex coronary PCIs were performed at our center. After excluding 393 non-planned cases, 201 CTO PCIs and 800 non-CTO PCIs were included. The mean follow-up was 2.5 ± 1.5 years. The composite endpoint occurred in 23 (11.6%) CTO PCIs and 219 (28.2%) planned non-CTO PCIs. The multivariable Cox regression using the CTO group as the reference showed a lower risk for the primary outcome (HR: 0.59; 95% CI 0.37–0.95; p = 0.031). After matching, a total of 195 adequately balanced pairs were obtained. The CTO group presented a lower risk for the primary combined outcome (HR: 0.46; 95% CI 0.27–0.76; p = 0.003). Conclusions: In patients undergoing planned complex PCI, those in the CTO group presented a reduced risk of all-cause death, myocardial infarction, and target vessel revascularization at the end of the follow-up.
No takes yet. Share an insight, caveat, or question.
Almendárez et al. (2025) conducted a cohort in Complex coronary artery disease (n=1,001). Chronic total occlusion (CTO) PCI vs. Planned complex non-CTO PCI was evaluated on Combined endpoint of all-cause death, myocardial infarction, and target vessel revascularization (HR 0.46, 95% CI 0.27-0.76, p=0.003). Chronic total occlusion PCI was associated with a lower risk of all-cause death, MI, and target vessel revascularization compared to planned complex non-CTO PCI.
Synapse has enriched 10 related papers. Consider them for comparative context: